HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chad G Rusthoven Selected Research
Chad G Rusthoven Research Topics
Disease
29
Neoplasms (Cancer)
04/2024 - 01/2014
23
Brain Neoplasms (Brain Tumor)
05/2024 - 11/2017
18
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2023 - 07/2015
11
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 01/2017
10
Lung Neoplasms (Lung Cancer)
04/2024 - 11/2015
8
Prostatic Neoplasms (Prostate Cancer)
04/2016 - 04/2014
6
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2014
5
Melanoma (Melanoma, Malignant)
05/2024 - 12/2017
4
Glioblastoma (Glioblastoma Multiforme)
01/2020 - 11/2014
4
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 01/2014
3
Glioma (Gliomas)
05/2021 - 11/2014
2
Renal Cell Carcinoma (Grawitz Tumor)
07/2023 - 01/2022
2
Breast Neoplasms (Breast Cancer)
01/2019 - 01/2018
2
Margins of Excision
11/2018 - 01/2017
2
B-Cell Lymphoma (Lymphoma, B Cell)
05/2016 - 01/2016
1
Central Nervous System Diseases (CNS Diseases)
01/2023
1
Necrosis
01/2023
1
Pneumonia (Pneumonitis)
01/2022
1
Neurologic Manifestations (Neurological Manifestations)
01/2022
1
Radiation Pneumonitis
01/2022
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2018
1
Stomach Neoplasms (Stomach Cancer)
09/2017
1
Adenocarcinoma
09/2017
1
Squamous Cell Carcinoma of Head and Neck
01/2017
1
Thymoma (Thymic Carcinoma)
01/2017
1
Nasopharyngeal Carcinoma
01/2017
1
Cholangiocarcinoma
07/2016
1
Neurofibrosarcoma (MPNST)
06/2015
1
Oligodendroglioma
11/2014
1
Astrocytoma (Pilocytic Astrocytoma)
11/2014
Drug/Important Bio-Agent (IBA)
6
Immune Checkpoint Inhibitors
IBA
10/2023 - 10/2018
4
Androgens
IBA
04/2016 - 01/2016
4
Prostate-Specific Antigen (Semenogelase)
IBA
04/2016 - 04/2014
2
Tyrosine Kinase Inhibitors
IBA
01/2023 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
05/2021 - 01/2017
2
Temozolomide (Temodar)
FDA Link
Generic
01/2017 - 01/2016
1
durvalumab
IBA
01/2023
1
Memantine (Namenda)
FDA Link
07/2022
1
Steroids
IBA
01/2022
1
SRS-A
IBA
11/2020
1
Ado-Trastuzumab Emtansine
IBA
01/2019
1
Anaplastic Lymphoma Kinase
IBA
01/2018
1
boldenone undecylenate (Equipoise)
IBA
12/2017
1
3-nitrophenyl 3-piperidinecarboxylate (MNPC)
IBA
01/2017
1
Rituximab (Mabthera)
FDA Link
05/2016
1
Bevacizumab (Avastin)
FDA Link
01/2014
Therapy/Procedure
48
Radiotherapy
04/2024 - 01/2014
19
Therapeutics
05/2024 - 01/2014
10
Drug Therapy (Chemotherapy)
01/2022 - 01/2014
8
Cranial Irradiation
01/2022 - 01/2017
3
Immunotherapy
05/2021 - 12/2017
3
Chemoradiotherapy
01/2019 - 01/2017
3
Combined Modality Therapy
07/2016 - 01/2016
2
Adjuvant Chemotherapy
06/2019 - 01/2019
2
Adjuvant Radiotherapy
09/2017 - 06/2015
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2017 - 05/2016
1
Aftercare (After-Treatment)
01/2023
1
Time-to-Treatment
01/2021
1
Radioimmunotherapy
01/2019
1
Neoadjuvant Therapy
01/2019
1
Hysterectomy
01/2019
1
Segmental Mastectomy (Lumpectomy)
01/2018
1
Re-Irradiation
01/2018
1
Retreatment
01/2018
1
Adjuvant Chemoradiotherapy
09/2017
1
Gastrectomy
09/2017
1
Brachytherapy
03/2016
1
Lymph Node Excision (Lymph Node Dissection)
07/2015
1
Prostatectomy (Retropubic Prostatectomy)
04/2014